Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tra...
Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract
About this item
Full title
Author / Creator
Liu, Hailing , Cao, Lei , Zhao, Xiaoli , Miao, Yi , Wu, Wei , Shi, Xiao , Zhang, Xiaoyan , Yin, Hua , Zhu, Huayuan , Xu, Wei , Li, Jianyong and Fan, Lei
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
The present study proposes metronomic chemotherapy (CPT), including prednisolone, cyclophosphamide, and thalidomide, as a treatment for patients with severe symptomatic indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract. The encouraging efficacy and excellent safety profile of CPT suggest the clinical potential of this combi...
Alternative Titles
Full title
Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10475756
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10475756
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/cas.15880
